Screening and surveillance for gastric cancer in the United States: Is it needed? Gwang Ha Kim, MD, PhD, Peter S. Liang, MD, Sung Jo Bang, MD, Joo Ha Hwang, MD, PhD Gastrointestinal Endoscopy Volume 84, Issue 1, Pages 18-28 (July 2016) DOI: 10.1016/j.gie.2016.02.028 Copyright © 2016 American Society for Gastrointestinal Endoscopy Terms and Conditions
Figure 1 Incidence of gastric cancers according to age and race in the United States, Japan, and Korea.5,41,42 Gastrointestinal Endoscopy 2016 84, 18-28DOI: (10.1016/j.gie.2016.02.028) Copyright © 2016 American Society for Gastrointestinal Endoscopy Terms and Conditions
Figure 2 Age-adjusted incidence rate of gastric cancer by race/ethnicity in the United States.4,16 Gastrointestinal Endoscopy 2016 84, 18-28DOI: (10.1016/j.gie.2016.02.028) Copyright © 2016 American Society for Gastrointestinal Endoscopy Terms and Conditions
Figure 3 Suggested screening algorithm for gastric cancer in the United States. †East Asia, Russia, and South America. ∗If there is a first-degree relative with gastric cancer, start screening 10 years before the age at diagnosis in the first-degree relative or age 50 (whichever is earlier). HP, H pylori; FHx, family history of gastric cancer; AG, atrophic gastritis; IM, intestinal metaplasia. Gastrointestinal Endoscopy 2016 84, 18-28DOI: (10.1016/j.gie.2016.02.028) Copyright © 2016 American Society for Gastrointestinal Endoscopy Terms and Conditions